← Evidence map

ArticleClinical rheumatology2026

TAPSE/PASP combined with IVC can identify poor prognosis in PAH patients with low and intermediate risk.

Wei Qian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2026

this papercites it

TAPSE/PASP combined with IVC can identify poor prognosis in PAH patients with low and intermediate risk. | OpenQuestion